logo-loader
Frontier IP Group PLC

Frontier IP Group - Notice of interim results

RNS Number : 4965G
Frontier IP Group plc
17 March 2020
 

RNS

AIM: FIPP

17 MARCH 2020

 

Frontier IP Group Plc

("Frontier IP" or the "Group")

 

 

Notice of interim results

 

 

Frontier IP, a specialist in commercialising intellectual property, today announces that it intends to publish its unaudited interim results for the half-year to 31 December 2019 on Wednesday 25 March 2020.

 

Key developments in the half year included an oversubscribed placing, which raised £3.8 million net of expenses, the incorporation of Elute Intelligence Holdings and Exscientia's collaboration with Rallybio, a US specialist in rare diseases. Results are expected to show significant progress.

 

Momentum has remained strong into the second half: the Vaccine Group ("TVG") has started work on a COVID-19 vaccine following validation and good progress with its novel vaccine platform technology; TVG and Fieldwork Robotics completed initial equity fundraisings; Cambridge Raman Imaging gained an EU Graphene Flagship grant; and Exscientia entered into a collaboration with Bayer AG. The Company has a robust balance sheet at the current time.

 

The Group looks forward to providing further details at the time of the interim results on 25 March 2020.

 

ENQUIRIES

 

Frontier IP Group Plc

 

Neil Crabb, Chief Executive Officer

Andrew Johnson, Communications & Investor Relations

Company website: www.frontierip.co.uk

T: 0207 332 2338

M: 07464 546 025

Allenby Capital Limited (Nominated Adviser)

T: 0203 328 5656

Nick Athanas / Nicholas Chambers 

 

N+1 Singer (Broker)

Harry Gooden / George Tzimas

 

 

 

 

 

T: 0207 496 3000

 

ABout frontier IP

Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services. A critical part of the Group's work is involving relevant industry partners at an early stage of development to ensure technology meets real world demands and needs.

The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NORKKOBDPBKDDND
NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...

FOR OUR FULL DISCLAIMER CLICK HERE

Frontier IP returns to profit with strategic portfolio advances

  Frontier IP Group PLC (AIM:FIPP) CEO Neil Crabb discusses the company's interim results in an interview with Proactive's Stephen Gunnion, highlighting a return to profitability and a good performance despite challenging market conditions. The firm reported a profit of £1.4 million in the...

1 week, 3 days ago

2 min read